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Besprechungen zentrale Fragen diskutieren konnte. Auch ohne Kaffee habe
ich jede Zeremonie genauso genossen.
Weiterhin danke ich Almut für’s “crazy camping” und die moralische Un-
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Abstract
Improvements in computational power eventually led to intensity modulated radiation ther-
apy (IMRT) and volumetric modulated arc therapy (VMAT) techniques. Since these tech-
niques offer many degrees of freedom, the choice of the treatment technique, the planning
system, the characteristics of the linear accelerator (linac) and the quality assurance (QA)
of the dose delivery are still discussed extensively. This thesis contributes to resolving the
main concerns of treatment technique, linac properties in terms of the MLC as well as the
QA potentials of commercially available 2D arrays with respect to plan-individual QA and
linac-oriented QA procedures.
First, a planning study, using constraint optimization and biologically oriented con-
straints, was designed such that the impact of the treatment delivery technique (static
IMRT, dynamic IMRT, VMAT) as well as the impact of major MLC design characteristics
(leaf width, interdigitation, leaf velocity) could be studied by means of dose to the tumor
(i.e. planning target volume - PTV) and plan characteristics, especially delivery time. It
is shown that the delivery technique has a larger impact on planning target volume (PTV)
coverage and treatment time than MLC design features. However, an improved MLC
design (especially smaller leaf width, higher leaf velocity and reduced transmission) con-
tributes to better PTV homogeneity and mean dose as well as to faster treatments for all
techniques.
Arrays of ion chambers or diodes are frequently used for the plan-individual QA. By
example of a head and neck case, the ability of three commercially available 2D arrays
and the subsequent evaluation with the widespread gamma method was investigated to
determine the extent to which MLC or dose miscalibrations can be revealed, as second
part of the thesis. Introduced errors of 1mm leaf miscalibration had already a large impact
on the dose distribution inside the patient, but the widely used gamma-evaluation with
the 3%/3mm ≤ 95% criterion did not detect these changes in the dose distribution using
either array for the measurement.
On the basis of these results, the complexity of IMRT and VMAT plans was decomposed
into their single components with suitable tests. Each array revealed specific shortcomings
with respect to small dose measurements and steep gradient resolution, which lead to a
different suitability for different checks for the regular verification of the MLC calibration
and complex plans with large number of small dose segments or low dose rate delivery.
Additionally, linac delivery limitations were found during ramp up and while very low
dose rate delivery. These results imply that plan-individual QA - at least based on the
measurement with arrays - might be inadequate for some plans. On the other hand, the
used arrays are suitable for constancy checks of the linac with respect to all important
delivery parameters for IMRT and VMAT.

Zusammenfassung
Verbesserungen der Rechenleistung führten zur intensitätsmodulierten Strahlentherapie
(IMRT) und volumetrischen modulierten Strahlentherapie (VMAT). Da diese Techniken
viele Freiheitsgrade bieten, wird weitläufig noch über die beste Technik, das Planungssys-
tem, die Eigenschaften des Beschleunigers und die Qualitätssicherung (QA) der Bestrah-
lung diskutiert. Die vorliegende Arbeit trägt zu diesen wesentlichen Punkten im Hinblick
auf die verwendete Bestrahlungstechnik, den Viel-Lamllen-Kollimator (MLC - multi-leaf
collimator) sowie das Potential von handelsüblichen 2D-Arrays für plan-individuelle QA
und beschleunigerorientierte QA-Verfahren bei.
Zunächst wurde eine Planungsstudie mit Einschränkungsoptimierung (constrained opti-
mization) und biologisch orientierten Optimierungsgrenzen so konzipiert, dass die Auswir-
kungen der Bestrahlungstechnik (statische IMRT, dynamische IMRT, VMAT) sowie die
Auswirkungen von grundlegenden MLC-Konstruktionsmerkmalen (Lamellenbreitebreite,
Interdigationsfähigkeit, Lamellen-Geschwindigkeit) anhand der Dosis im Tumor (d.h. im
Planungszielvolumen - PTV) und den Planeigenschaften, wie insbesondere der Abstrahl-
zeit, evaluiert werden können. Es zeigt sich, dass die Bestrahlungstechnik einen größeren
Einfluss auf die PTV-Abdeckung und die Bestrahlungszeit hat als MLC-Konstruktionsmerk-
male. Dennoch trägt ein verbessertes MLC-Design (insbesondere kleinere Lamellenbreite,
höhere Lamellengeschwindigkeit und reduzierte Transmission) zur besseren PTV-Homogeni-
tät und PTV-Dosis sowie zur schnelleren Bestrahlungszeit für alle Techniken bei.
Für die plan-individuelle QA werden häufig Arrays mit Ionisationskammern oder Dioden
verwendet. Beispielhaft wurde in einem zweiten Projekt für einen HNO-Plan die Eignung
von drei handelsüblichen 2D-Arrays untersucht, inwiefern MLC- oder Dosisfehlkalibrierun-
gen messtechnisch festzustellen sind. Zur Auswertung wurde die weit verbreitete Gamma-
Index-Methode verwendet. Eingeführte Fehler von 1mm Lamellen-Fehlkalibrierung haben
bereits großen Einfluss auf die Dosisverteilung innerhalb des Patienten. Diese wurden je-
doch von der Gamma-Auswertung mit dem oft verwendeten 3%/3mm ≤ 95%-Kriterium
bei der Messung mit keinem der Arrays entdeckt.
Auf Grundlage dieser Ergebnisse wurde die Komplexität von IMRT- und VMAT-Plänen
mittels geeigneter Tests in ihre Einzelkomponenten zerlegt. Jedes Array zeigte spezifische
Mängel in Bezug auf die Messung kleiner Dosen und steiler Dosisgradienten, die zu einer un-
terschiedlichen Eignung der Arrays für die regelhafte Überprüfung der MLC-Kalibrierung
und komplexer Pläne mit einer großen Anzahl an Segmenten mit kleinen Dosen oder einer
niedrigen Dosisleistung führen. Darüber hinaus wurden Einschränkungen des Beschleuni-
gers während des Einschaltprozesses und beim Strahlen mit sehr niedriger Dosisleistung
gefunden. Diese Ergebnisse implizieren, dass plan-individuelle QA - zumindest bei Messung
mit Arrays - für einige Pläne unzureichend sein könnte. Andererseits sind die verwendeten
VIII Zusammenfassung
Arrays für Konstanzprüfungen des Beschleunigers für alle wichtigen Bestrahlungsparame-
ter bei IMRT und VMAT geeignet.
1 Introduction
Radiation therapy evolved quickly in the last 20 years due to large improvements of com-
putational power, which made
- routine use of computed tomography (CT) for treatment planning,
- routine use of multi-leaf collimators (MLCs) in digital linacs to better conform the
dose to the tumor,
- dose calculation based on CT, and increasing use of Monte Carlo methods and
- efficient (inverse) optimization algorithms for treatment planning systems (TPSs)
available.
Large improvements in treatment technique followed. While in former times, the treated
volume was scarcely conformed to the tumor, conformance is not only very well today but
also dose painting (different dose levels for different tumor areas) and almost online adaptive
treatment planning (adapting dose to the actual geometry of the patient shortly before or
during the daily treatment) are possible.
These advancements formed modern treatment techniques, which can be summarized as
modulated radiation therapy techniques: these comprise IMRT in static (step-and-shoot
or static IMRT - sIMRT) and dynamic (dynamic sliding window - dMLC) mode as well as
VMAT (volumetric modulated arc therapy).
With these technical improvements, the requirements for the quality assurance (QA) of
the treatment chain (fig. 1.1) from CT over TPS to dose delivery at the linac increased and
the dose engines, which calculate the dose on the planning CT, got more sophisticated.
Additionally, modulated radiation therapy techniques introduced dose delivery based on
superimposed often small beams, which are formed by the MLC of the linac.
The presented thesis comprises studies with respect to treatment planning and the QA
of the dose delivery by the linac. Especially the influence of the treatment technique and
MLC (as part of the linac properties) as well as the measurement device and its potential
impact on QA philosophy are regarded.
1.1 Modulated radiation therapy techniques
Within the group of modulated radiation therapy techniques, step-and-shoot or static
IMRT (sIMRT) is the closest to the most often used technique of 3D conformal radiation
therapy (3DCRT). In 3DCRT, tumor (gross tumor volume - GTV) and organs of risk
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Figure 1.1: Treatment chain from treatment planning to delivery (green), including main factors
(orange) affecting treatment and plan quality.
(OARs) are contoured on a 3D CT dataset of the patient. With margins for microscopic
disease (clinical target volume - CTV), patient movement and setup inaccuracies a PTV
is generated (fig. 1.2). The physician decides about the dose to the PTV and OARs. The
physicist decides about entrance directions, shape and intensity of the beams (fields), such
that the physician’s intent is fulfilled. This results in simple to low complexity plans with
one to about 10 to 15 single fields. The main delivery property in 3DCRT is that all parts
of the treatment device (linac) are fixed while one field is being delivered (tab. 1.1).
Also in sIMRT, the beam is only switched on while all linac parts are fixed. In contrast
to 3DCRT, the dose to the PTV can be better conformed in sIMRT, as optimization
algorithms divide one field into several sub-fields (segments). Therefore, this so called “step
and shoot” IMRT superimposes not only the fluence from several directions (3DCRT) but
also the fluence of several differently shaped beams for one direction (tab. 1.1). Thereby,
the fluence from one direction is no longer limited to the simple beam profile (flat or
wedged), but can be modified using differently shaped beams with different intensity. As
this approach enables better conformance to complex (especially concave) formed tumors,
OARs can be spared more efficiently. This makes additional tight (daily) setup control
of the patient necessary, which - by itself could also possibly result in the confidence that
reduced PTV setup margin can be used and thereby an even more conformal treatment
can be planned. Still, dose is only delivered while all parts of the linac are fixed which
results in longer treatment times compared to 3DCRT.
In contrast to sIMRT, dose in dMLC mode is delivered while the radiation beam is
switched on (from one fixed gantry position). This means that the beam is no longer paused
to change the field size but the fluence is delivered by sweeping the beam limiting devices
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Figure 1.2: Volume definition according to ICRU 62 [1].
gross tumor volume (GTV) = gross tumor volume: macroscopic tumor
clinical target volume (CTV) = clinical target volume: GTV + margin accounting
for microscopic tumor
ITV= internal target volume: CTV + margin accounting for tumor motion (espe-
cially used for stereotactic treatments of lung and liver)
PTV = planning target volume: ITV + margin accounting for patient motion, daily
setup uncertainties and linac delivery uncertainties
treated volume = volume covered by dose, which is regarded appropriate to achieve
the purpose of treatment (often 95% of the prescribed dose to the PTV)
irradiated volume = volume receiving dose that is considered significant for normal
tissue
Table 1.1: Differences between 3DCRT and modulated treatment techniques
technique fluence division into
segments (subfields)
dose rate variation
while beam-on
moving linac parts
while beam-on
3DCRT no no none
sIMRT yes no none
dMLC yes yes MLC
VMAT yes yes MLC, gantry
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(MLC and jaws) across the field and simultaneously controlling the dose rate between two
control points (tab. 1.1). These control points can be regarded as start and end point of
one segment. Therefore, dMLC adds the complexity of changing field size and variable
dose rate, which fastens the treatment. The dynamic delivery also challenges the dose
computation since instead of static, clearly defined beam outlines and MU, the dose has
to be calculated from the partial leaf opening which depends on the actual leaf speed and
dose rate between two control points. For two sweeping gaps of the same width to deliver
the same dose across the field with different dose rates, the leaf speed has to be adapted
accordingly. As the actually delivered dose rate may depend on daily and intra-treatment
variation, the leaf speed has to be adapted from control point to control point during
treatment and is controlled by the linac contol unit. Therefore, the fluence optimization
as well as the dose computation have to challenge the estimation of the leaf movement
and varying dose rate, that is only estimated by means of a sequence of control points.
Furthermore, the linac control unit interprets the planned control point sequence and may
merge several consecutive control points or may create new control points in between two
control points initially created by the TPS. Consequently, the assumed constant leaf speed
and constant dose rate between two planned control points may not be delivered as planned
and thereby result in dose delivery different from the planned dose distribution.
Additionally to dMLC, the gantry is moving and changing its speed in VMAT mode,
meaning that not only the beam shape and dose rate, but also the gantry position are
controlled simultaneously (tab. 1.1). This makes treatments in VMAT technique poten-
tially even faster than dMLC delivery. On the other hand, the moving gantry adds another
degree of complexity to the delivery and optimization in the same manner as described
above for dMLC delivery. Therefore, VMAT can be regarded as more complex than the
introduction of changing field outline in dMLC (compared to sIMRT) alone, as both the
leaf speed and the gantry speed have to be synchronized with the dose rate and its varia-
tions. This complexity in treatment technique has to be evenly adapted into a clinical QA
routine procedure.
1.2 Design components of multi-leaf collimators
Multi-leaf collimators (MLCs) are used to define the field outline of the radiation beam.
MLCs consist of two opposing leaf banks on which several small “leaf-like” absorbers,
that can be moved almost independently, are mounted. Perpendicular to the leaf travel
direction, one large jaw is mounted per side. Important for the plan generation are the
leaf travel limits, width of the leaf, its transmission through leaf body, leaf tip, adjacent
(tongue-and-grove) and opposing leaves (minimal leaf gap). Important for the treatment
time is the leaf travel velocity. An overview of MLC components and design is shown in
figure 1.3.
The leaf width is essential with respect to conformance and OAR sparing as larger leaves
may not effectively block small structures. Too narrow leaves on the other hand will not
effectively block radiation. Leaf travel limits have to balance weight and construction limits
1.2 Design components of multi-leaf collimators 5
Figure 1.3: MLC design and components.
a) schematic beams eye view of the Elekta Agility MLC (drawing adapted from [2])
b, c, d) additional design components of a MLC influencing transmission (redrawn
from [3])
b) schematic diagram of rounded leaf end shape
c) example of tongue-and-groove design between adjacent leaves
d) schematic drawing of the influence of the leaf position to the leaf and beam ray
geometry
of the linac head with the MLCs functionality to deliver dose to several parts of the PTV,
as often used in modulated radiation therapy. This means that a compact construction
with capability to travel over the isocenter line and interdigitation is wanted, but with the
least possible transmission. As transmission results in dose even to blocked regions, too
large transmission will result in smaller modulation potential in the optimization and thus
minor quality of the treatment plan. To prevent colliding opposing leaves - especially in
dynamic mode - opposing leaves will not close beyond a minimal leaf gap. Dose through this
minimal leaf gap may depend on the off-axis position and may also degrade plan quality,
if large with respect to dose deposition. Therefore, backup jaws to hide the minimal leaf
gap can be used instead of designing the leaves such that the dose deposition due to this
gap is minimal in large off-axis positions.

2 Plan optimization of modulated
radiation therapy techniques
2.1 Constrained optimization
The fluences, which should be delivered by the linac in the different techniques, are cal-
culated based on CT data of the patient. Instead of predefining the beam shape and its
fluence manually as it is done in 3DCRT, better results are obtained by inverse optimization
algorithms.
Challenges of the optimization process in modulated radiation therapy are the transla-
tion of the physician’s intent into optimization constraints using the given resources, which
include the optimization algorithm as well as available delivery technique, linac and MLC.
The physician’s intent is normally given as dose (D) or volume (V) constraints (DV=x%,
VD=xGy), comprising minimal, maximal or mean dose as well as percentage of volume not
to exceed a certain dose. These constraints can be either translated as one point in the
dose to volume relation (dose-volume-histogram (DVH))[4] (fig. 2.1a) or as function of the
whole DVH curve (fig. 2.1b+c). The latter is often related to biological models of radiation
effects in tissue expressed as tumor control probability (TCP) and normal tissue complica-
tion probability (NTCP). To approximate the radiation effects, the inhomogeneous dose
distributions - especially in OARs - are converted into equivalent uniform dose (EUD) [5–
7]. This uniform dose is supposed to cause the same NTCP (or TCP) as the real inhomoge-
neous dose. Depending on the response of tissue to radiation, a tissue specific factor within
the model is tuned. While single DVH point constraints might not be representative for
the dose distribution of a single OAR and introduce local minima in the objective function,
EUD based constraints are able to control the whole DVH and can be related to the biolog-
ical effect of the delivered dose, even though more evidence for the dose-effect-relationship
is necessary [8]. Further enhancement can be accomplished by constrained optimization.
This method guarantees the given constraints while maximizing dose to the tumor under
the given constraints. Using cost functions, which are able to control the DVH, instead of
single point DVH constraints, the optimization is more efficient and the input parameters
better relate to the physician’s intent. [9]
Compared to 3DCRT, modulated delivery techniques have shown to improve either
TCP or NTCP or both using diverse optimization algorithms and different MLCs [11–27].
On the one hand, this is possible due to improvements in treatment technique, as non-
flat fluences better conform to the PTV and improve the homogeneity inside the PTV.
On the other hand, delivery improvements with modern linacs result in more conformal
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Figure 2.1: Influence of different definitions of constraint functions to the DVH.
a) simple dose-volume constraints impact on one single point of the DVH (redrawn
from [4])
b) constraint reducing the maximal dose using a serial dose-effect-relationship and
thereby controlling the high dose part of the DVH with increasing weight towards
higher doses, as indicated by the arrows (redrawn from [10])
c) constraint reducing a given dose-volume-relation using a parallel dose-effect-
relationship and thereby controlling large parts of the DVH, with an increas-
ing weight towards the given dose-volume-relation, as indicated by the arrows
(redrawn from [10])
treatments, because of smaller MLC leaf width, which better conforms to complex-formed
PTVs and blocks OARs more effectively. Furthermore, the ability of the MLC and linac to
deliver the treatment faster due to higher leaf speed and higher dose rate enables smaller
safety margins, as the patient and its organs have less time to move. So far, studies have
investigated either the impact of treatment technique or MLC to certain treatment sites. As
studies were undertaken by several authors, the used techniques, resources (like TPS, beam
model or optimization algorithm), linac-MLC-combinations and reported parameters were
different. Therefore comparability as well as conclusions about the impact of the treatment
technique and the MLC are limited.
2.2 Impact of technique and MLC
Isolating the impact of the treatment technique and advancements due to MLC improve-
ments, plans should be generated using the same beam model and optimization regime.
Therefore, a treatment planning study was conducted for medium to challenging prescrip-
tions, to assess plan quality in terms of target coverage, dose to critical OAR and clinically
important plan parameters. Depending on the used technique and used MLC, the op-
timization has different degrees of freedom. One aim of this thesis was to quantify the
impact of delivery technique and MLC with respect to plan quality in terms of dose to the
tumor, sparing of OARs and treatment time. Nine plans with all combinations of sIMRT,
dMLC and VMAT with three different MLCs for five meningioma and five head-and-neck
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patients were evaluated.
The research treatment planning system (TPS) Hyperion (University of Tübingen, re-
search tool to the commercially available TPS Monaco) was used, as constrained optimiza-
tion guarantees the physician’s intent, introduced as cost functions into the optimization.
Besides fulfilling the constraints while maximizing dose to the PTV, this TPS offers bio-
logically related cost functions. In the beginning of the optimization, the constraints were
set such that the physicians intent was achieved. In the following optimization steps, the
constraints were tightened where possible such that the PTV was just covered by the pre-
scribed dose. This can be achieved by running the optimization with harder constraints
compared to the physician’s intent, such that each constraint can just be fulfilled instead
of being loose and offering tolerance for the optimization. All constraints were found for
the plan with the highest degrees of freedom, which was a VMAT plan using a MLC with
0.5 cm leaf width and with interdigitating capabilities.
The presented planning study (author’s contribution A) provides the first study to dis-
tinguish the influence of the delivery technique and the MLC by largely eliminating the
influence of the optimization and dose calculation algorithms. By using constraint opti-
mization and tightly restricting the dose to organs at risk during the optimization, the
effects of treatment delivery technique (sIMRT, dMLC, VMAT) and different MLC de-
signs on tumor dose and treatment time were studied. It was found that the delivery of
VMAT is fastest without sacrificing dose to the tumor or OAR constraints. In conjunction
with small and fast driving leaves, the delivery is not only accelerated, but also improved
with respect to PTV dose. As intended by the use of constraint optimization, dose to
OARs was the same for all generated treatments plans for each patient, while mean dose
and dose homogeneity as well as treatment time improved with more complex techniques
(sIMRT<dMLC<VMAT). However, the influence of the MLC design is smaller than the
influence of the delivery technique. While interdigitation does not add much to the plan
quality in terms of the dose distribution, it may reduce treatment time for some (complex)
cases and thereby enhances delivery efficiency. Smaller leaf width, on the other hand, im-
proves dose homogeneity to the tumor as well as PTV mean dose, if small structures in the
vicinity of the PTV have to be spared. Especially faster leaf speed accelerates the treat-
ment time, which largely improves patient comfort and minimizes organ motion during
treatment.
Author Contribution
For this planning study, the first author (=author of this thesis) is responsible for the
the manuscript draft, the concept of the study, patient enrolment, plan generation, data
collection and acquisition as well as literature revision with contributions of co-authors to
each part as defined in the publication.

3 Quality Assurance of modulated
treatment plans
3.1 Setup of treatment planning system
Since calculated dose distributions are virtual, the correct delivery by the linac has to be
verified. Starting with the correct beam model in the TPS and the correct data transfer
to the linac, the delivery by the linac itself as well as the suitability of the measurement
device has to be guaranteed.
The beam model inside the TPS characterizes the linac and provides the base for the
dose calculation engine, which calculates based on the CT data how dose is delivered to the
patient (fig.3.1). To characterize the linac, measurements of square fields are collected in a
large water phantom with single detectors. The measurements include depth dose profiles
and profiles across the middle axes of the field in several depths. Mainly ion chambers and
diode detectors are used. While ion chambers lack resolution in steep penumbra regions
due to the volume averaging effect, shielded diodes may overestimate dose due to low
energies in out-of-field-regions and large depths due to the density perturbation effect.
Especially small fields should therefore be measured with more than one detector [28].
For all modulated techniques, but especially for dynamic techniques, MLC parameters
concerning transmission through the leaf tip, the leaf body, adjacent leaves (tongue-and-
grove) and small leaf gaps between opposing leaves (minimal leaf gap) as well as leaf
scatter contributions have a large impact on the agreement of the calculation with the
measurement of IMRT plans. [29]
The calculated plan is expressed in control points, with each one defining the position of
the gantry, jaws, leaf positions and delivered dose in terms of monitor unitss (MUs). These
control points are stored in a DICOM-RT plan file, which will be interpreted by the linac
control unit. A linac log file stores surrogate values for each parameter (e.g. potentiometer
values) while treatment. These surrogate values of the log file can be translated into
a “delivered” DICOM-RT plan file, which can be compared to the original DICOM-RT
plan file. Since this plan verification approach may suffer from timely uncertainties of the
treatment log frequency and potential miscalibrations, measurements of the treatment plan
are still the most often used plan verifications.
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Figure 3.1: schematic overview of the treatment delivery head and its simulation parts in the
treatment planning system.
The beam model handles the constant parts, e.g. energy; the plan-individual beam
shape is optimized based on the MLC properties. This gives the plan-individual
fluence, which is used by the dose engine to calculate the dose distribution on the
patient based on the treatment planning CT (drawing adapted from [30]).
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3.2 Measurement devices
In the beginning of IMRT, relative film measurements in one plane in combination with
a one point ion chamber measurement to check the absolute dose were used. As film
measurements are time and cost intensive and one point ion chamber measurements may
lack accuracy in steep dose gradients, multi-detector 2D arrays were invented and used
instead. For the QA of sIMRT and dMLC, these 2D arrays were mostly not irradiated
from the originally planned gantry angle but from gantry angle 0◦, as this was easy to
accomplish by setting up the measurement device on the table top. With the advent of
VMAT, QA methods including gantry movement became necessary, as gantry speed, dose
rate and leaf speed influence each other. One possibility is to attach the used 2D array
to the gantry. A second approach is to use the electronic portal imaging device (EPID)
for dose measurement, which was originally introduced for the patient setup verification.
Furthermore, so-called 3D arrays, which are different cylindrical measurement devices for
the rotational needs of VMAT, were introduced with different detector arrangements (diode
detectors beneath the surface, two crossed 2D diode arrays in the middle of the cylinder,
rotating cylinder with one 2D ion chamber array in the middle).
EPIDs consist of amorphous silicon photodiodes behind a film transistor and scintillator
material. Cumbersome calibrations are necessary to convert the measured signal to dose,
as EPIDs are energy dependent. Therefore corrections for field size, off-axis, low dose as
well as dose rate, ghosting and image lag have to be introduced. These characteristics may
degrade the measurement, if not studied and implemented correctly. [31–34]
In contrast to EPIDs, 2D and 3D arrays may suffer from resolution due to the volume
effect (if ion chambers are used) and the distance between single measurement points as well
as their geometrical arrangement. Contrary, the measurement principles are well known
and can be corrected much easier, if necessary.
3.3 Linac- and plan-individual quality assurance
For 3DCRT, QA procedures monitor the basic components of the treatment delivery sys-
tem, such as dose, dose linearity, dose rate linearity, profile stability in different gantry
angles and correct field size. The appropriate tests are established according to national
(e.g. DIN) and international (e.g. AAPM reports) guidelines. As in 3DCRT open, clearly
defined fields and beam arrangements are used, effects to the patient plan in case of mis-
calibrations of any delivery component can be anticipated quite easily. Therefore, a linac-
oriented QA procedure is regarded as appropriate.
With overlaying several open fields of varying intensity, like in sIMRT, the effects of
any miscalibrations to a patient plan may not be as clear as in 3DCRT. Therefore, linac-
oriented QA as was used so far for 3DCRT is regarded as insufficient and plan-individual
QA was introduced. Since measurements inside the patient are not possible, the plan is
irradiated to a phantom and the resulting surrogate dose distribution is analyzed - either
field by field or the entire plan. Starting with cumbersome film measurements, 2D and 3D
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Figure 3.2: Illustration of the Γ-value in a) 2D and b) 1D. (redrawn from [35])
arrays as well as EPIDs made plan-individual QA much faster with the potential to review
the whole delivered dose distribution. By measuring the delivered fluence with respect to
the gantry angle, there will be no longer a limitation to a dose distribution inside a certain
phantom. Instead, a “measured” dose distribution can be calculated on the planning CT
and compared to the original plan calculation. As an alternative to measurements, linac-
log files can be evaluated. Surrogate parameters of all linac parameters, e.g. MLC position,
dose rate or gantry position, are logged, which can be used to calculate the delivered dose
distribution on a CT dataset.
Regardless of the method used for plan-individual QA, the evaluation can mask short-
comings of the plan, because of the measurement itself or the dose comparison metrics.
Comparing dose distributions, the gamma-evaluation method [35] is most popular. This
method combines a comparison in terms of predefined dose difference (∆D, termed dose
difference criterion) and distance (∆d, termed distance-to-agreement criterion or DTA
criterion). For each dose point in the tested (e.g. measured) distribution rm the distance
r(rm, rc) and the dose difference δ(rm, rc) to the reference (e.g. calculated) dose distribution
within a certain radius are calculated. The geometric mean of both with respect to the
predefined criteria is termed gamma value Γ (fig.3.2):
Γ =
√
r2(rm, rc)
∆d2
+
δ2(rm, rc)
∆D2
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with the geometric distance r between the measured rm and calculated rc dose point:
r(rm, rc) = |rc − rm|
and the dose difference δ between the measured rm and calculated rc dose point:
δ(rm, r) = D(rc)−D(rm)
The lowest gamma value found for one point is regarded as closest match to the reference
distribution and used for further evaluation. As long as this gamma value is Γ ≤ 1,
the tested and reference dose point are within the predefined criteria. Subsequent to the
evaluation of all single points, the percentage of all points of the distribution with Γ ≤ 1
is termed as gamma pass rate γ. During the last years, the gamma pass rate calculated
for ∆D ≤ 3% dose difference and ∆d ≤ 3mm distance to agreement being larger than
95% of all evaluated points (γ3%/3mm ≥ 95%) got gradually established in clinical routine
[36]. However, several studies show, that γ pass rates of different measurement devices are
not comparable and, that tighter pass criteria (lower dose difference or smaller distance to
agreement or larger pass rate or all) would be necessary to detect patient relevant delivery
errors. [37–45] Furthermore, one could argue about treatment site or case specific pass
criteria.
A small study with one nine field sIMRT and one nine field dMLC head-and-neck patient
plan was conducted during this thesis, to show the impact of leaf and dose miscalibrations
of 1 to 3mm and 1 to 3%, respectively, to the dose distribution inside the patient as well
as to the gamma-evaluation, when measuring with three different 2D arrays. The dose
distribution showed large differences, especially when altering the leaves. Leaf position
manipulations of 1mm had larger impact on OARs than monitor units (MU) manipulations
of 3%, while the difference between techniques was minimal. The change of OAR dose
depends on target proximity and extent of sparing. The largest deviation was found for
the spinal cord, which was surrounded by the PTV. Altering the leaves by 1mm already
resulted in a change of the maximal dose of 3Gy. Altering the leaves by 3mm changed
the maximal dose of the spinal cord by 12Gy. The mean dose in the PTV changed by
at least 1.3Gy (sIMRT) and 2.2Gy (dMLC), when altering the leaves by 1mm (fig.3.3).
Therefore, the evaluation of the measurement should reveal leaf miscalibrations of 1mm, as
these can be patient relevant. The measurement with different 2D arrays and subsequent
gamma-evaluation (mean of γ pass rate of the nine fields) showed different results for
different arrays and that ion chamber arrays require a dose difference criterion of 2% and
a distance-to-agreement criterion of 2mm; the used diode arrays can be used with the
widely used 3% and 3mm criterion, but with a pass rate of at least 98% for sIMRT and
96% for dMLC. Even though these results may be case specific, this study shows that the
gamma-evaluation method, especially with the widely used γ3%/3mm ≥ 95% criteria, can
hide patient relevant miscalibrations. (fig.3.4)
In order to find reasons for this insensitivity of the measurements, the complexity of
modulated treatment plans (sIMRT, dMLC and VMAT) was decomposed into its basic
components, for which simple tests were composed. Using the same geometry for all three
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Figure 3.3: Impact of leaf or dose miscalibration to the DVHs of the PTV, spinal cord and
contra lateral parotid for on example sIMRT head-and-neck case.
L refers to changed leaves, which were opened (+) or closed (-) by 1, 2 or 3mm in
each segment.
M refers to changed dose in terms of MU, which were increased (+) or decreased
(-) by 1, 2 or 3% for each segment with respect to the total plan MU
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Figure 3.4: Mean γ pass rate for the evaluated sIMRT and dMLC head-and-neck example case,
when using ∆D = 3% and ∆d = 3mm criterion. As indicated in red, 95% pass rate
is not suitable to find the introduced patient relevant leaf and dose errors of 1mm
and 2%, respectively.
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arrays that were used for the previous miscalibration study, these tests were delivered to
the arrays using one single linac. Main results were verified on two matched linacs (author’s
contribution B).
The presented study of three of the most popular 2D arrays provides the first consistent
measurements of these devices and shows influences of the device as well as linac delivery
characteristics to QA results. This was achieved by decomposing the delivery complexity in
modulated radiation therapy into its single components. It was found that linac instabilities
exist during the ramp up phase and while delivering small dose rates. The measurement
devices lack linear dose measurement for small doses and low dose rates to different extent.
Especially in plan-individual QA, these aspects need to be considered as parameters that
may degrade either the plan delivery in general, the measurement or the obtained results so
that, eventually, the plan-individual QA procedure might be non-meaningful. Therefore,
plan QA should already start while planning by considering linac delivery constraints
during the optimization process. Furthermore, tight linac-oriented QA, that checks the
limits used during plan generation, can provide enough confidence about the correct plan
delivery without extensive and only partially meaningful plan-individual QA.
Author Contribution
For this study of measurement devices, the first author (=author of this thesis) is respnsible
for the the manuscript draft, the concept of the study, measurement paradigms, data
collection, aquisition and analysis as well as literature revision. Co-authors contributed to
single sections and detailed question of each part. All co-authors read and approved the
manuscript.
4 Conclusion
Two of the main quality concerns in planning of modulated treatment techniques were
investigated: The impact of MLC properties and delivery technique and the potential of
current measurement devices for effective quality assurance.
Treatment plan quality, only judged by the dose distribution calculated on CT, is affected
to a higher degree by the use of more complex techniques like VMAT than by MLC design.
Including patient comfort and organ motion during treatment into the evaluation of plan
quality, MLC improvements like fast driving leaves are essential as well as this will shorten
treatment time.
Furthermore, the correct delivery is a crucial criterion for plan quality as the dose distri-
bution is assumed to be delivered as planned. Effective QA methods should thus include
the characteristics of the measurement device in case of plan-individual QA. In contrast,
evaluating shortcomings of the delivery in advance and including these findings into the
treatment planning process offers the opportunity for improved plan delivery quality based
on tight linac QA instead of time-consuming plan QA and re-planning in case of failing
plan QA.
To date, neither efficient linac QA nor plan constraints that consider delivery and mea-
surement shortcomings during the planning phase are implemented into routine QA pro-
cedures. While the discussed linac QA methods using 2D arrays have proven to be mean-
ingful, these tests have to be implemented into clinical routine workflow additionally to
known plan QA. To fully abandon plan QA and rely on the suggested extended linac QA,
exact plan and plan QA inspection will be necessary to distinguish between non-optimal
plan generation, degraded plan delivery, measurement or evaluation method. This can
eventually lead to eliminating plans with poor delivery quality during the planning process
and to increased confidence in linac QA.
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